{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 461752878
| IUPAC_name = 4-amino-5-chloro-''N''-(2-diethylaminoethyl)-2-(3-oxobutan-2-yloxy)benzamide
| image = Batanopride.png

<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_status = Uncontrolled
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 102670-46-2
| ATC_prefix = none
| ATC_suffix =  
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 38594
| PubChem = 59692
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 1AT99K728N
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 53849
| smiles = Clc1cc(c(OC(C(=O)C)C)cc1N)C(=O)NCCN(CC)CC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C17H26ClN3O3/c1-5-21(6-2)8-7-20-17(23)13-9-14(18)15(19)10-16(13)24-12(4)11(3)22/h9-10,12H,5-8,19H2,1-4H3,(H,20,23)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = ZYOJXUNLLOBURP-UHFFFAOYSA-N

<!--Chemical data-->
| C=17 | H=26 | Cl=1 | N=3 | O=3 
| molecular_weight = 355.860 g/mol
}}

'''Batanopride''' ('''BMY-25,801''') is an [[antiemetic]] [[drug]] of the [[benzamide]] class which acts as a [[binding selectivity|selective]] [[5-HT3 receptor|5-HT<sub>3</sub> receptor]] [[receptor antagonist|antagonist]].<ref>Gylys JA, Wright RN, Nicolosi WD, Buyniski JP, Crenshaw RR. BMY-25801, an antiemetic agent free of D2-dopamine receptor antagonist properties. ''Journal of Pharmacology and Experimental Therapeutics''. 1988 Mar;244(3):830-7. {{PMID|2978041}}</ref> It was trialled to reduce nausea during cancer chemotherapy, but was never approved for medical use due to dose-limiting side effects including [[hypotension]] and [[long QT syndrome]].<ref>Fleming GF, Vokes EE, McEvilly JM, Janisch L, Francher D, Smaldone L. Double-blind, randomized crossover study of metoclopramide and batanopride for prevention of cisplatin-induced emesis. ''Cancer Chemotherapy and Pharmacology''. 1991;28(3):226-7. {{PMID|1855280}}</ref>

== References ==
{{Reflist}}

{{Antiemetics}}
{{Serotonergics}}

[[Category:5-HT3 antagonists]]
[[Category:Antiemetics]]
[[Category:Benzamides]]
[[Category:Phenol ethers]]
[[Category:Anilines]]
[[Category:Chloroarenes]]


{{gastrointestinal-drug-stub}}